Literature DB >> 2895848

Immunological reactivity and bioactivity of tumour necrosis factor.

C M Petersen, B K Møller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895848     DOI: 10.1016/s0140-6736(88)91735-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias.

Authors:  S H Lim; C Worman; A Jewell; C Tsakona; F J Giles; A Goldstone
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.

Authors:  M H Bemelmans; J W Greve; D J Gouma; W A Buurman
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

Review 3.  Tumour necrosis factor: a cytokine with multiple biological activities.

Authors:  G Semenzato
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

4.  Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity.

Authors:  J S Economou; M Hoban; J D Lee; R Essner; S Swisher; W McBride; D B Hoon; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.

Authors:  D Kwiatkowski; J G Cannon; K R Manogue; A Cerami; C A Dinarello; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.